Bright Minds Biosciences Inc. Made Big Gain
Mon, Aug 22, 2022 at 06:55 PM
Bright Minds Biosciences Inc. (DRUG:NASDAQ) jumped higher at $2.16, a gain of 72.8%. On Mon, Aug 22, 2022, DRUG:NASDAQ hit a New 2-Week Intraday High of $3.45. From Mon, Aug 08, 2022, the stock recorded 30.00% Up Days and 45.45% Green Days
The stock spiked on Thu, Aug 18, 2022 at $4.75 with a volume of 119M+.
About Bright Minds Biosciences Inc. (DRUG:NASDAQ)
Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain.
Top 10 Gainers:
- Bright Minds Biosciences Inc. (DRUG:NASDAQ), 72.8%
- AnPac Bio-Medical Science Co., Ltd. (ANPC:NASDAQ), 66.01%
- Social Capital Suvretta Holdings Corp. I (DNAA:NASDAQ), 48.26%
- Summit Therapeutics plc (SMMT:NASDAQ), 48.18%
- Minerva Neurosciences, Inc. (NERV:NASDAQ), 47.83%
- Wag! Group Co. (PET:NASDAQ), 47.01%
- Bon Natural Life Limited (BON:NASDAQ), 36.45%
- Signify Health Inc. Class A (SGFY:NYSE), 32.08%
- Reviva Pharmaceuticals Holdings Inc. (RVPH:NASDAQ), 30.68%
- Blue Apron Holdings, Inc. (APRN:NYSE), 26.34%